ZIVO Bioscience Company Description
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers.
The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.
It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging.
The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014.
ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
| Country | United States |
| Founded | 1983 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | John Payne |
Contact Details
Address: 2125 Butterfield Drive Troy, Nevada 48084 United States | |
| Phone | 248 452 9866 |
| Website | zivobioscience.com |
Stock Details
| Ticker Symbol | ZIVO |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US98978N2009 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| John Bernard Payne | President, Chief Executive Officer and Chairman of the Board |
| Keith R. Marchiando | Chief Financial Officer, Treasurer and Secretary |
| Dr. Harlan L. Miller III | Vice President of Technology and Global Supply |